PhageTech closes $2.4 million Series A financing for commercialization of one minute blood and urine test. Funding boosts development of breakthrough biosensor technology radically simplifying disease detection (September 28, 2015 – Irvine, CA) PhageTech, Inc. today announced that it has…
Funding boosts development of breakthrough biosensor technology radically simplifying disease detection IRVINE, Calif., Oct. 1, 2015 /PRNewswire-USNewswire/ — EvoNexus Irvine company PhageTech, Inc. announced that it has raised $2.4 million in Series A funding from a group of early stage…
Funding boosts development of breakthrough biosensor technology radically simplifying disease detection (September 28, 2015 – Irvine, CA) PhageTech, Inc. today announced that it has raised $2.4 million in Series A funding from a group of early stage investors co-led by…
(Orange County Business Journal, September 28, 2015) – Irvine-based PhageTech Inc. said it closed on $2.4 million in Series A financing to complete development and U.S. Food and Drug Administration approval for disease sensor technology and to commercialize a blood…